No Data
No Data
Repare Therapeutics: A Strong Buy on Robust Financials and Promising Clinical Pipeline
Repare Therapeutics Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
It's been a good week for Repare Therapeutics Inc. (NASDAQ:RPTX) shareholders, because the company has just released its latest first-quarter results, and the shares gained 8.7% to US$3.64. Reve
Repare Therapeutics Shares Rise 17% After 1Q Earnings, Revenue Beats
By Chris Wack Repare Therapeutics shares were up 17% to $3.85 after the company reported first-quarter earnings that beat analysts' expectations. The company reported quarterly earnings of $13 milli
Express News | Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Small Cap Bid Up Following Key Q1 Earnings Beat
whaleeeeeeeeeeeeeeee : why izzit tanking wtheck
TrytosaveabitOP whaleeeeeeeeeeeeeeee: Not enough buy side pressure! Sells from shorts and some profit takers is just putting to much downward pressure with not enough volume to push back! GL